Get the Stockscreener App
71.95
4.64%
-3.50
Transmedics Group Inc stock is traded at $71.95, with a volume of 1.19M.
It is down -4.64% in the last 24 hours and up +26.83% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$75.45
Open:
$75.89
24h Volume:
1.19M
Relative Volume:
0.61
Market Cap:
$2.41B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
76.54
EPS:
0.94
Net Cash Flow:
$-120.51M
1W Performance:
-0.32%
1M Performance:
+26.83%
6M Performance:
-58.40%
1Y Performance:
-17.29%
1-Day Range:
$71.50
$76.78
1-Week Range:
$71.50
$80.00
52-Week Range:
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
71.95 | 2.41B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
TMDX CLASS ACTION DEADLINE: TransMedics Group, Inc. Investors with Losses are Notified of Ongoing Lawsuit – Contact BFA Law by April 15 Deadline - GlobeNewswire Inc.
Kirby McInerney LLP Reminds TransMedics Group, Inc. (TMDX) - GlobeNewswire
Lowey Dannenberg Notifies TransMedics Group, Inc. - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group - Markets Insider
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman - PR Newswire
Lost Money on TransMedics Group, Inc. (TMDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics LawsuitTMDX - Morningstar
TMDX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. (TMDX) - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransMedics - GlobeNewswire
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman - GlobeNewswire
TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
TMDX FRAUD LAWSUIT: TransMedics Group Investors that Lost - GlobeNewswire
TMDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
TRANSMEDICS GROUP, INC. (NASDAQ: TMDX) INVESTOR ALERT: - GlobeNewswire
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Purchased by Peregrine Capital Management LLC - MarketBeat
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed - GlobeNewswire
(TMDX) Investment Analysis and Advice - Stock Traders Daily
Baillie Gifford & Co. Increases Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
NASDAQ: TMDX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against TransMedics Group, Inc. - The Malaysian Reserve
TransMedics Group (TMDX) Expected to Announce Earnings on Monday - MarketBeat
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - TradingView
TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
TransMedics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - The Eastern Progress Online
Lowey Dannenberg, P.C. is Investigating TransMedics Group, - GlobeNewswire
TransMedics Group, Inc. Stockholder Notice: Shareholder - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming DeadlinesTMDX - PR Newswire
TMDX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. Investors - Business Wire
TransMedics to Present at Upcoming March Investor Conferences - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group - Business Wire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Short Interest in TransMedics Group, Inc. (NASDAQ:TMDX) Increases By 23.8% - MarketBeat
Gladstone Institutional Advisory LLC Makes New $615,000 Investment in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TMDX INVESTOR NOTICE: TransMedics Group, Inc. Investors - GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages TransMedics Group, - GlobeNewswire
TMDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire
TMDX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Investor Alert: Robbins LLP Informs Stockholders of the TransMedics Group, Inc. Class Action - PR Newswire
Janney Montgomery Scott LLC Purchases New Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group, Inc.'s (NASDAQ:TMDX) 26% Jump Shows Its Popularity With Investors - Simply Wall St
TMDX CLASS ACTION ALERT: Scorpion Capital Report Triggers - GlobeNewswire
Yousif Capital Management LLC Purchases 1,652 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Sapient Capital LLC Has $209,000 Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Receives $122.70 Average PT from Analysts - MarketBeat
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
TMDX INVESTOR ALERT: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
TransMedics Group (NASDAQ:TMDX) Stock Price Down 6.8%Time to Sell? - MarketBeat
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics - GlobeNewswire
TMDX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khayal Tamer I | Chief Commercial Officer |
Jan 07 '25 |
Sale |
80.05 |
1,083 |
86,694 |
20,843 |
| Khayal Tamer I | Chief Commercial Officer |
Dec 02 '24 |
Option Exercise |
13.28 |
1,084 |
14,396 |
21,927 |
| Khayal Tamer I | Chief Commercial Officer |
Dec 02 '24 |
Sale |
86.40 |
1,084 |
93,658 |
20,843 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Option Exercise |
38.46 |
1,458 |
56,075 |
22,301 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Sale |
90.04 |
1,458 |
131,278 |
20,843 |
| Basile Edward M | Director |
Nov 05 '24 |
Option Exercise |
28.12 |
6,750 |
189,810 |
7,482 |
| Basile Edward M | Director |
Nov 05 '24 |
Sale |
83.55 |
6,750 |
563,994 |
732 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Option Exercise |
13.28 |
1,083 |
14,382 |
21,926 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Sale |
82.64 |
1,083 |
89,499 |
20,843 |
1.16%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):